Phenomic Studies on Diseases: Potential and Challenges
Open accessThe DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The rapid development of such research field as multi-omics and artificial intelligence (AI) has made it possible to acquire and analyze the multi-dimensional big data of human phenomes. Increasing evidence has indicated that phenomics can provide a revolutionary strategy and approach for discovering new risk factors, diagnostic biomarkers and precision therapies of diseases, which holds profound advantages over conventional approaches for realizing precision medicine: first, the big data of patients' phenomes can provide remarkably richer information than that of the genomes; second, phenomic studies on diseases may expose the correlations among cross-scale and multi-dimensional phenomic parameters as well as the mechanisms underlying the correlations; and third, phenomics-based studies are big data-driven studies, which can significantly enhance the possibility and efficiency for generating novel discoveries. However, phenomic studies on human diseases are still in early developmental stage, which are facing multiple major challenges and tasks: first, there is significant deficiency in analytical and modeling approaches for analyzing the multi-dimensional data of human phenomes; second, it is crucial to establish universal standards for acquirement and management of phenomic data of patients; third, new methods and devices for acquirement of phenomic data of patients under clinical settings should be developed; fourth, it is of significance to establish the regulatory and ethical guidelines for phenomic studies on diseases; and fifth, it is important to develop effective international cooperation. It is expected that phenomic studies on diseases would profoundly and comprehensively enhance our capacity in prevention, diagnosis and treatment of diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multi-omic integration frameworks combine genomic, transcriptomic, epigenomic, and clinical information to improve disease diagnosis and identify candidate therapeutic targets, leveraging multimodal learning strategies to capture cross-modal biological associations [12, 13].”
From The next paradigm in bioinformatics: a review of multi-agent systems and foundational models for end-to-end scientific discovery (2026) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci‐Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38098 · Cited by 3,409
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · cited 2×
“Since aging is a key risk factor for a number of major diseases, the aging of the society is leading to significant increases in the patients of age-related diseases (Campisi et al. 2019; Hou et al. 2019; North and Sinclair 2012; Partridge et al. 2018).”
BackgroundMulti-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953 · cited 3×
“…basis of the following development: first, there has been rapid development of multi-omics technologies that include genomics, proteomics, metabolomics, radiomics, epigenomics, transcriptomics and microbiomics (Hasin et al. 2017; Leon-Mimila et al. 2019; Olivier et al. 2019; Panunzio et al. 2021).”
BackgroundInfluentialThe intersection between aging and cardiovascular disease
North, B. J., & Sinclair, D. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246876 · Cited by 1,585 · cited 1×
“Since aging is a key risk factor for a number of major diseases, the aging of the society is leading to significant increases in the patients of age-related diseases (Campisi et al. 2019; Hou et al. 2019; North and Sinclair 2012; Partridge et al. 2018).”
BackgroundFacing up to the global challenges of ageing
Partridge, L., Deelen, J., & Slagboom, P. E. (2018) · Nature · doi:10.1038/s41586-018-0457-8 · Cited by 1,475 · cited 2×
“Since aging is a key risk factor for a number of major diseases, the aging of the society is leading to significant increases in the patients of age-related diseases (Campisi et al. 2019; Hou et al. 2019; North and Sinclair 2012; Partridge et al. 2018).”
BackgroundShi, F., Wang, J., Shi, J., Wu, Z., Wang, Q., Tang, Z., He, K., Shi, Y., & Shen, D. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2020.2987975 · Cited by 1,404 · cited 1×
“AI technology has played an increasingly important role in CT image analyses (Shi et al. 2021).”
BackgroundFrom discoveries in ageing research to therapeutics for healthy ageing
Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E. (2019) · Nature · doi:10.1038/s41586-019-1365-2 · Cited by 1,389 · cited 2×
“One example for this type of study is phenomic study on human aging: human aging is highly complex and systemic alterations of the biological properties of human body, which can be affected by multiple mechanisms (Campisi et al. 2019).”
BackgroundHoule, D., Govindaraju, D. R., & Omholt, S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2897 · Cited by 1,279 · cited 3×
“Increasing evidence has indicated the significance and urgency for applications of phenomics in studying diseases (Delude 2015; Houle et al. 2010; Newgard and Attie 2010; Nicholson 2021; Zhang et al. 2021).”
BackgroundHellmann, M. D., Nathanson, T., Rizvi, H., Creelan, B. C., Sanchez-Vega, F., Ahuja, A., Ni, A., Novik, J. B., Mangarin, L. M. B., Abu-Akeel, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.018 · Cited by 1,095
Russell, E., Koren, G., Rieder, M., & Van Uum, S. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.009 · Cited by 1,063 · cited 1×
“Sixth, multiple studies have indicated that the pathological changes of the hair may become diagnostic biomarkers for multiple diseases (D’Anna-Hernandez et al. 2011; Denny et al. 2013; Price et al. 1980; Russell et al. 2012; Yamada et al. 2007).”
Background
Cited by
Yan, P., Liu, J., Li, Z., Wang, J., Zhu, Z., Wang, L., & Yu, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010315 · Cited by 73
“Various other environmental exposures are also associated with IPF, including exposure to metals and wood dust, agriculture and farming, viruses, and silica [7–10].”
BackgroundChen, Y., Bai, M., Liu, M., Zhang, Z., Jiang, C., Li, K., Chen, Y., Xu, Y., & Wu, L. (2025) · Cancer Medicine · doi:10.1002/cam4.71317 · Cited by 72
Boros, A., Szólik, E., Desalegn, G., & Tőzsér, D. (2024) · Agronomy · doi:10.3390/agronomy15010076 · Cited by 78
“Further, compliance with data sharing and privacy standards often hinders the adequate exploitation of technological potential [314].”
Shi, W., Wang, Y., Xu, C., Li, Y., Ge, S., Bai, B., Zhang, K., Wang, Y., Zheng, N., Wang, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35797-6 · Cited by 50
Data Interoperability and Harmonization in Cardiovascular Genomic and Precision Medicine
Chahal, C. A. A., Alahdab, F., Asatryan, B., Addison, D., Aung, N., Chung, M. K., Denaxas, S., Dunn, J., Hall, J. L., Pamir, N., et al. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.124.004624 · Cited by 46
“101 It is apparent that the complexity of harmonizing multiple platforms and data sets, in different languages, which have been built on different hosting systems, compounds the implementation complexity of this endeavor into clinical workflows that impact health care.”
Metadata
- Authors
- Ying, W.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Ying, Weihai
- ORCID
- Ying, Weihai
- Venue
- Phenomics
- Published
- 2023-01-05
- Volume
- 3
- Issue
- 3
- Pages
- 285-299
- ISSN
- 2730-583X (ISSN-L)
- 2730-5848
- PMC
- PMC9867904
- OpenAlex
- W4318543005
- Cited by
- 96
- References
- 138
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 36 · 2023: 9
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Phenomics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Shanghai Municipality (2017SHZDZX01)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- multi-omics, artificial intelligence, precision medicine, diagnostic biomarkers, disease risk factors, international cooperation, big data analytics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenomic Studies on Diseases: Potential and Challenges. https://app.cochat.ai/papers/10.1007/s43657-022-00089-4
- The paper
- Ying, W. (2023). Phenomic Studies on Diseases: Potential and Challenges. Phenomics. https://doi.org/10.1007/s43657-022-00089-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.